Please note that some translations using Google Translate may not be accurately represented, and image captions and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result for using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Ewing sarcoma is a type of cancer that grows in bones or soft tissues. The tumor was first described by a pathologist, Dr. James Ewing, in the 1920's. Most often, it is found in the bones of the pelvis or thigh, though it can arise throughout the body.
Ewing sarcoma tends to strike children and young adults between the ages of 5 and 20, and is more common in boys than in girls. Fortunately, treatments for Ewing sarcoma have improved dramatically in recent years, and most children who develop this disease have a good chance for recovery with proper treatment.
Children diagnosed with Ewing sarcoma are treated through the Bone and Soft Tissue Tumor Program at Dana-Farber/Boston Children's Cancer and Blood Disorders Center. Our specialists — including pediatric oncologists, surgical oncologists and radiation oncologists — offer a level of expertise in bone and soft tissue tumors rarely seen at other pediatric cancer centers. We provide the full set of options that can be used to treat Ewing sarcoma, and our specialists can help you determine which option is best for your child.
Find in-depth information on Ewing sarcoma on the Dana-Farber/Boston Children's website, including details on Ewing sarcoma causes, symptoms, diagnosis and treatment.
Appointments and Second Opinions